Korro Bio KRRO
NASDAQ KRRO
$9.64 -0.07 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Price to Sales (2020 - 2026)

Updated

Korro Bio's (KRRO) Price to Sales stood at 81.37 in Q2 2026, up 335.7% from 18.67 a year earlier and up 138.1% from the prior quarter.

Analysis

Korro Bio (KRRO) Price to Sales (2020 - 2026) Analysis & Trends

For FY2025, Korro Bio's Price to Sales came in at 11.80, down 92.5% from FY2024.

  • Across earlier years, Price to Sales came in at 157.20 in FY2024 and 631.06 in FY2021 (-61.0%).
  • The Q2 2026 figure is the highest quarterly Price to Sales since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at 34.17 (Q1 2026), 11.80 (Q4 2025) and 61.06 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Korro Bio 142.79 Mn -253.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.37
Mar 31, 2026 34.17
Dec 31, 2025 11.80
Sep 30, 2025 61.06
Jun 30, 2025 18.67
Mar 31, 2025 33.91
Dec 31, 2024 157.20
Mar 31, 2022 393.70
Dec 31, 2021 631.06
Sep 30, 2021 507.82
Jun 30, 2021 485.59
Mar 31, 2021 472.86
Dec 31, 2020 1,619.04
Sep 30, 2020 1,020.69
Jun 30, 2020 812.08
API Access

Korro Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=KRRO&period=max&api_key=YOUR_API_KEY